Access!, AAM’s annual meeting for the generics and biosimilars industry, brings policymakers, influential speakers and industry leaders together to share knowledge and ideas. This year virtual Access! is May 26-27.
Physicians and hospitals play a critical role in biosimilar adoption. This paper highlights the importance of examining ways to remove obstacles that may discourage providers from utilizing lower-cost biosimilars with their patients.
US Only: Biosimilars have the potential to generate savings for patients and the US healthcare system. Recently, Len Arsenault, @DrSameerAwsare and @christinsimmon discussed how stakeholders can increase uptake and continue #PioneeringAccessForPatients. https://bddy.me/3zgdhKM